CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-12-15 | Truffle Capital S.A.S. 10% owner | Other acquisition | +5,784 | 93,947 | ||
| 2017-12-15 | Truffle Capital S.A.S. 10% owner | Other acquisition | +4,337 | 42,773 | ||
| 2017-12-15 | Novartis Bioventures Ltd 10% owner | Other acquisition | +65,718 | 2,357,975 | ||
| 2017-12-13 | Truffle Capital S.A.S. 10% owner | Other acquisition | +16,018 | 141,163 | ||
| 2017-12-13 | Truffle Capital S.A.S. 10% owner | Other acquisition | +21,357 | 88,163 | ||
| 2017-12-13 | Truffle Capital S.A.S. 10% owner | Other acquisition | +16,018 | 38,436 | ||
| 2017-12-13 | Truffle Capital S.A.S. 10% owner | Other disposition · Series B Convertible Preferred Stock | −22.77 | 159.36 | ||
| 2017-12-13 | Truffle Capital S.A.S. 10% owner | Other disposition · Series B Convertible Preferred Stock | −30.35 | 212.48 | ||
| 2017-12-13 | Truffle Capital S.A.S. 10% owner | Other disposition · Series B Convertible Preferred Stock | −22.77 | 159.36 | ||
| 2017-12-13 | Novartis Bioventures Ltd 10% owner | Other acquisition | +242,694 | 2,292,257 | ||
| 2017-12-13 | Novartis Bioventures Ltd 10% owner | Other disposition · Series B Convertible Preferred Stock | −344.94 | 2,414.57 | ||
| 2017-12-07 | SCHAFFER DERACE L Director | Purchase | +7,639 | $1.74 | $13K | 344,913 |
| 2017-12-06 | SCHAFFER DERACE L Director | Purchase | +16,106 | $1.80 | $29K | 337,274 |
| 2017-12-05 | SCHAFFER DERACE L Director | Purchase | +13,495 | $1.78 | $24K | 321,168 |
| 2017-12-04 | SCHAFFER DERACE L Director | Purchase | +7,300 | $1.81 | $13K | 307,673 |
| 2017-12-01 | SCHAFFER DERACE L Director | Purchase | +5,215 | $1.80 | $9K | 300,373 |
| 2017-11-30 | SCHAFFER DERACE L Director | Purchase | +12,978 | $1.84 | $24K | 295,158 |
| 2017-11-29 | SCHAFFER DERACE L Director | Purchase | +7,942 | $1.94 | $15K | 282,180 |
| 2017-11-28 | SCHAFFER DERACE L Director | Purchase | +12,395 | $1.97 | $24K | 274,238 |
| 2017-11-27 | SCHAFFER DERACE L Director | Purchase | +10,042 | $2.00 | $20K | 261,843 |
Page 28 of 29 · 568 trades